(Q54669456)

2 June 2018

title

A substrate-like form of plasminogen-activator-inhibitor type 1. Conversions between different forms by sodium dodecyl sulphate (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1425706

25 September 2022

T. Urano

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1425706

25 September 2022

L. Strandberg

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1425706

25 September 2022

L. B. Johansson

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1425706

25 September 2022

T. Ny

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1425706

25 September 2022

language of work or name

English

0 references

publication date

1 November 1992

1 reference

2 June 2018

published in

FEBS Journal

1 reference

2 June 2018

volume

209

1 reference

2 June 2018

issue

3

1 reference

2 June 2018

page(s)

985-992

1 reference

2 June 2018

An inhibitor from placenta specifically binds urokinase and inhibits plasminogen activator released from ovarian carcinoma in tissue culture

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1992.TB17372.X

Kinetics of the inhibition of plasminogen activators by the plasminogen-activator inhibitor. Evidence for 'second-site' interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1992.TB17372.X

Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1992.TB17372.X

The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1992.TB17372.X

Plasminogen activator inhibitor type-1: reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1992.TB17372.X

Circular dichroic analysis of protein conformation: inclusion of the beta-turns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1992.TB17372.X

Structural basis of latency in plasminogen activator inhibitor-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1992.TB17372.X

Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1992.TB17372.X

10.1111/J.1432-1033.1992.TB17372.X

21 January 2018

Identifiers

DOI

1 reference

2 June 2018

1 reference

2 June 2018